About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Massachusetts | 382 Studies

Clinical Trials Pancreatic CancerMassachusetts

Pancreatic Cancer Clinical Trials in Massachusetts

Find 382 clinical trials for pancreatic cancer near Massachusetts. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 382 trials

CompletedStudy Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.The purpose of this study is to determine whether investigational study drug, AG-013736, and gemcitabine are effective in the first-line treatment of advanced pancreatic cancer.NCT00471146·Antioch, California and 203 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedLDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic CancerLDE225 is a new medicine that blocks the Hedgehog (Hh) pathway.NCT01485744·Boston, Massachusetts and 1 other

CompletedA Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic CancerPrecision Promise is a multi-center, seamless Phase 2/3 platform trial designed to evaluate multiple regimens in metastatic pancreatic cancer.NCT04229004·La Jolla, California and 24 others

CompletedPerioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical ResectionThe purpose of this research study is to addresses the challenge of managing the unique perioperative needs of older cancer patients undergoing surgical resection.NCT02810652·Boston, Massachusetts

RecruitingA Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H MutationPhase I Study of NT-175, an autologous T cell therapy product genetically engineered to express an HLA-A\*02:01-restricted T cell receptor (TCR), targeting TP53 R175H mutant…NCT05877599·Gilbert, Arizona and 22 others

CompletedNeoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic CancerA standard treatment for pancreatic cancer is radiation therapy plus chemotherapy after surgery. Radiation therapy and chemotherapy are commonly given for up to six weeks.NCT00438256·Boston, Massachusetts and 1 other

Active not recruitingTemozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine TumorsThis randomized phase II trial studies how well giving temozolomide with or without capecitabine works in treating patients with advanced pancreatic neuroendocrine tumors.NCT01824875·Anaheim, California and 322 others

WithdrawnFeasibility Study of LUM Imaging System for Pancreatic CancerThis single-site, non-randomized, open-label study to assess the initial safety and efficacy of the LUM Imaging System for detection of primary pancreatic cancer and peritoneal…NCT04276909·Boston, Massachusetts

CompletedPasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsThe purpose of this research study is to determine the safety of the combination of SOM230 and RAD001, as well as determine the highest dose of this combination that can be given…NCT00804336·Boston, Massachusetts and 2 others

CompletedTMS for the Treatment of Pancreatic Cancer PainThis is a phase II study that aims to investigate prospectively a new therapy for a cohort of patients with chronic pain attributed to pancreatic cancer.NCT00324428·Boston, Massachusetts

CompletedA Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic AdenocarcinomaThis is a randomized, open-label, multi-center, phase 3 study of napabucasin plus weekly nab-paclitaxel with gemcitabine versus weekly nab-paclitaxel with gemcitabine for adult…NCT02993731·Birmingham, Alabama and 266 others

RecruitingStudy of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )The purpose of this study is to evaluate the efficacy of an investigational RAS(ON) inhibitor administered in combination with chemotherapy compared to placebo in combination with…NCT07621718·Tucson, Arizona and 8 others

Active not recruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple…NCT02465060·Birmingham, Alabama and 1409 others

CompletedA Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid TumorsThis clinical trial is an interventional, active-treatment, open-label, multi-center, Phase 1/2 study.NCT03997968·San Francisco, California and 15 others

CompletedBPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer PatientsThis is a Phase 2 multicenter, open-label, non-randomized study to examine the safety and effectiveness of BPM31510 administered over 144-hours (two 72-hour 110mg/Kg doses)…NCT02650804·Gilbert, Arizona and 11 others

RecruitingA Study of Sigvotatug Vedotin in Advanced Solid TumorsThis trial will look at a drug called sigvotatug vedotin (SGN-B6A) alone and with pembrolizumab, with or without chemotherapy, to find out whether it is safe for people who have…NCT04389632·Anchorage, Alaska and 157 others

UnknownPANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing RegimenThe objectives of this multi-center, randomized, controlled trial are to evaluate the safety and efficacy of PANVAC-VF in combination with Granulocyte-macrophage…NCT00088660·Mobile, Alabama and 61 others

RecruitingAcoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic CancerThe purpose of the study is to assess the efficacy and safety of Acoustic Cluster Therapy (ACT) when given in addition to chemotherapy for treatment of Locally Advanced Pancreatic…NCT06850623·Scottsdale, Arizona and 9 others

UnknownTissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesTo collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and…NCT05635266·Waltham, Massachusetts

CompletedBMS-247550 in Treating Patients With Advanced Pancreatic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00016965·Mobile, Alabama and 94 others

PreviousPage 5 of 20Next

Other Conditions in Massachusetts

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia